{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T04:57:04Z","timestamp":1770094624125,"version":"3.49.0"},"reference-count":31,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"unspecified","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MRC","award":["MR\/N013638\/1"],"award-info":[{"award-number":["MR\/N013638\/1"]}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2023-01807"],"award-info":[{"award-number":["2023-01807"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Region Stockholm, ALF Medicin","award":["FoUI-986028"],"award-info":[{"award-number":["FoUI-986028"]}]},{"name":"Swedish Heart and Lung Foundation","award":["20230371"],"award-info":[{"award-number":["20230371"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["bmjmed"],"accepted":{"date-parts":[[2025,12,11]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop new risk prediction equations for kidney failure in patients with chronic kidney disease who do not require data for the urine albumin to creatinine ratio.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Stockholm Creatinine Measurements (SCREAM) database of routinely collected electronic healthcare records in primary and outpatient care from the region of Stockholm, Sweden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>116\u2009158 adults with chronic kidney disease stages 3-4, defined by two estimated glomerular filtration rate (eGFR) results of &lt;60\u2009to \u226515\u2009mL\/min\/1.73\u2009m\u00b2, at least 90 days apart, with no intermediate eGFR value \u226560\u2009mL\/min\/1.73\u2009m\u00b2, between 1 January 2010 to 31 December 2018.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measure<\/jats:title>\n                    <jats:p>Kidney failure, defined as starting kidney replacement therapy, recorded within five years of the index date.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Based on temporal split sample validation, development and validation cohorts included 85\u2009012 patients (736 kidney replacement therapy events) and 28\u2009338 patients (114 kidney replacement therapy events), respectively. After Cox regression with automated backwards selection, the final model included 10 predictors (in order of significance): eGFR, age, diabetes, sex, atrial fibrillation, antihypertensive drugs, peripheral artery disease, reduction in eGFR slope, acute kidney injury, and hypertension. Model discrimination was excellent in both the development cohort (C statistic 0.941, 95% confidence interval (CI) 0.932 to 0.951) and validation cohort (C statistic 0.944, 0.923 to 0.965). In 26\u2009229 patients with data for the urine albumin to creatinine ratio, the four variable kidney failure risk equation (KFRE) showed marginal improvement in discrimination over our new equation (C statistic 0.950, 95% CI 0.942 to 0.958 for KFRE\n                      <jats:italic>v<\/jats:italic>\n                      0.926, 0.915 to 0.936, for the new equation). KFRE under-estimated the risk in the study cohort, however, with an observed-expected event probability ratio of 2.11, suggesting that recalibration is required.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The findings of the study indicate that predicting the risk of kidney failure with high accuracy in a general population of patients with chronic kidney disease is possible based on data that are routinely available, without requiring data for the urine albumin to creatinine ratio.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjmed-2025-001950","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T16:15:11Z","timestamp":1770048911000},"page":"e001950","source":"Crossref","is-referenced-by-count":0,"title":["Developing a new albuminuria-free risk prediction equation for kidney failure in patients with chronic kidney disease: retrospective cohort study"],"prefix":"10.1136","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8401-2305","authenticated-orcid":false,"given":"Faye","family":"Cleary","sequence":"first","affiliation":[{"name":"Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK"},{"name":"Medical Research Council Integrative Epidemiology Unit, Population Health Sciences, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5001-0061","authenticated-orcid":false,"given":"David","family":"Prieto Merino","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK"},{"name":"Faculty of Medicine, University of Alcal\u00e1, Alcala de Henares, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4920-623X","authenticated-orcid":false,"given":"Rupert","family":"Major","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, Leicester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4763-2024","authenticated-orcid":false,"given":"Juan Jesus","family":"Carrero","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"},{"name":"Division of Nephrology, Department of Clinical Sciences, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5767-248X","authenticated-orcid":false,"given":"Dorothea","family":"Nitsch","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"2026020208450951000_5.1.e001950.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kisu.2021.11.003"},{"key":"2026020208450951000_5.1.e001950.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60439-0"},{"key":"2026020208450951000_5.1.e001950.3","article-title":"Chronic kidney disease: a public health problem that needs a public health action plan","volume":"3","author":"Schoolwerth","year":"2006","journal-title":"Prev Chronic Dis"},{"key":"2026020208450951000_5.1.e001950.4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158765","article-title":"Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"key":"2026020208450951000_5.1.e001950.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30045-3"},{"key":"2026020208450951000_5.1.e001950.6","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw330"},{"key":"2026020208450951000_5.1.e001950.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041031"},{"key":"2026020208450951000_5.1.e001950.8","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"key":"2026020208450951000_5.1.e001950.9","doi-asserted-by":"crossref","unstructured":"Steyerberg EW . Clinical prediction models: a practical approach to development, validation and updating. 2nd edn. Switzerland AG: Springer Nature, 2019.","DOI":"10.1007\/978-3-030-16399-0"},{"key":"2026020208450951000_5.1.e001950.10","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaa188"},{"key":"2026020208450951000_5.1.e001950.11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-074819","article-title":"Evaluation of clinical prediction models (part 1): from development to external validation","volume":"384","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"2026020208450951000_5.1.e001950.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-074820","article-title":"Evaluation of clinical prediction models (part 2): how to undertake an external validation study","volume":"384","author":"Riley","year":"2024","journal-title":"BMJ"},{"key":"2026020208450951000_5.1.e001950.13","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-014-0241-z","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement","volume":"13","author":"Collins","year":"2015","journal-title":"BMC Med"},{"key":"2026020208450951000_5.1.e001950.14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.451"},{"key":"2026020208450951000_5.1.e001950.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.18202"},{"key":"2026020208450951000_5.1.e001950.16","unstructured":"National Institute for Health and Care Excellence . Chronic kidney disease: assessment and management. NICE guideline NG203. 2021. Available: https:\/\/www.nice.org.uk\/guidance\/ng203\/resources\/chronic-kidney-disease-assessment-and-management-pdf-66143713055173 [Accessed 01 May 2024]."},{"key":"2026020208450951000_5.1.e001950.17","unstructured":"Nitsch D , Caplin B , Hull S . First national CKD audit report. 2017. Available: https:\/\/www.lshtm.ac.uk\/files\/ckd_audit_report.pdf [Accessed 01 May 2024]."},{"key":"2026020208450951000_5.1.e001950.18","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.121.17323"},{"key":"2026020208450951000_5.1.e001950.19","unstructured":"National Audit Office . NHS financial management and sustainability (session 2024-25). Available: https:\/\/www.nao.org.uk\/wp-content\/uploads\/2024\/07\/nhs-financial-management-and-sustainability.pdf [Accessed 28 Jul 2025]."},{"key":"2026020208450951000_5.1.e001950.20","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfv117"},{"key":"2026020208450951000_5.1.e001950.21","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw354"},{"key":"2026020208450951000_5.1.e001950.22","unstructured":"National Institute for Health and Care Excellence . Diabetes: ACEi or ARBs. Available: https:\/\/www.nice.org.uk\/indicators\/ind134-diabetes-ac-ei-or-ar-bs\/IND134-20241219.pdf [Accessed 07 Nov 2025]."},{"key":"2026020208450951000_5.1.e001950.23","doi-asserted-by":"publisher","DOI":"10.1177\/1536867x1001000303"},{"key":"2026020208450951000_5.1.e001950.24","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X12470757"},{"key":"2026020208450951000_5.1.e001950.25","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i6","article-title":"Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests","volume":"352","author":"Vickers","year":"2016","journal-title":"BMJ"},{"key":"2026020208450951000_5.1.e001950.26","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020071077"},{"key":"2026020208450951000_5.1.e001950.27","doi-asserted-by":"crossref","DOI":"10.1186\/s41512-023-00157-x","article-title":"Using the kidney failure risk equation to predict end-stage kidney disease in CKD patients of South Asian ethnicity: an external validation study","volume":"7","author":"Maher","year":"2023","journal-title":"Diagn Progn Res"},{"key":"2026020208450951000_5.1.e001950.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.01.009"},{"key":"2026020208450951000_5.1.e001950.29","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078063","article-title":"Predicting the risks of kidney failure and death in adults with moderate to severe chronic kidney disease: multinational, longitudinal, population based, cohort study","volume":"385","author":"Liu","year":"2024","journal-title":"BMJ"},{"key":"2026020208450951000_5.1.e001950.30","unstructured":"Office for Health Improvement & Disparities (OHID) and NHS Benchmarking Network . CVDPREVENT second annual audit report 2022 (for the audit period up to March 2021). Available: https:\/\/s3.eu-west-2.amazonaws.com\/nhsbn-static\/CVDPREVENT\/2022\/338%20CVDPREVENT%20Second%20Annual%20Audit%20Report%20FINAL.pdf [Accessed 01 May 2024]."},{"key":"2026020208450951000_5.1.e001950.31","doi-asserted-by":"publisher","DOI":"10.3399\/BJGP.2022.0145"}],"container-title":["BMJ Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjmed-2025-001950","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T16:45:20Z","timestamp":1770050720000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjmedicine.bmj.com\/lookup\/doi\/10.1136\/bmjmed-2025-001950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2,2]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/bmjmed-2025-001950"],"URL":"https:\/\/doi.org\/10.1136\/bmjmed-2025-001950","relation":{},"ISSN":["2754-0413"],"issn-type":[{"value":"2754-0413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}